Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Smartphone Optical Sensor Diagnoses Kaposi's Sarcoma

By LabMedica International staff writers
Posted on 27 Jun 2013
A smartphone-based system has been created for in-the-field detection of the herpes virus that causes Kaposi's sarcoma, a type of cancer linked to Acquired Immunodeficiency Syndrome (AIDS).

The system consists of a plug-in optical accessory and disposable microfluidic chips, and the technique could also be adapted for use in detecting a range of other conditions, from Escherichia coli infections to hepatitis. More...


Biomedical engineers at Cornell University (Ithaca, NY, USA) devised and used the smartphones for diagnostic testing, which unlike other methods, this system is chemically based and does not use the phone's built-in camera. Instead, gold nanoparticles are combined or conjugated with short DNA snippets that bind to Kaposi's DNA sequences, and a solution with the combined particles is added to a microfluidic chip.

In the presence of viral DNA, the particles clump together, which affects the transmission of light through the solution. This causes a color change that can be measured with an optical sensor connected to a smartphone via a micro-USB (universal serial bus) port. The nanoparticle solution is a bright red when little or no Kaposi's virus DNA is present, but at higher concentrations, the solution turns a duller purple, providing a quick method to quantify the amount of Kaposi's DNA. The main advantage of the system compared to previous Kaposi's detection methods is that users can diagnose the condition with little training.

David Erickson, PhD, who devised the technique said, “The accessory provides an ultraportable way to determine whether or not viral DNA is present in a sample.” Matthew Mancuso, a doctoral student in Prof. Erickson’s laboratory added, “The smartphone reader could also work with other color-changing reactions, such as the popular enzyme-linked immunosorbent assays (ELISA), a common tool in medicine to test for human immunodeficiency virus (HIV), hepatitis, food allergens, and E. coli. The laboratory has also created smartphone accessories for use with the color-changing strips in pH and urine assays. These accessories could form the basis of a simple, at-home, personal biofluid health monitor.” The study was presented at the Conference on Lasers and Electro Optics held June 9-14, 2013, in San Jose (CA, USA).

Related Links:

Cornell University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.